Using a novel in vivo model to study the function of nuclear factor kappa B in cerebral ischemic injury

Medical Science Monitor

Volumn 18, Issue 11, 2012, Pages

  Wang, Rui ^a   Liang, Songlan ^a   Yue, Hui ^a   Chen, Lijie ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus; Cerebral ischemia; Inflammation; Neurionoprotect; NF B

Indexed keywords

ACETYLCYSTEINE; ADENOVIRUS VECTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SYNAPTOTAGMIN I; TRIPHENYLTETRAZOLIUM;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN TISSUE; CONTROLLED STUDY; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

EID: 84868564096     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.883539     Document Type: Article

References (25)

1. del Zoppo G, Ginis I, Hallenbeck JM et al: Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol, 2009; 10: 95-112
2. Mehta SL, Manhas N, Raghubir R: Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev, 2007; 54: 34-66
3. Bernard SA, Gray TW, Buist MD et al: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med, 2002; 346: 557-63
4. Xu T, Gong Z, Zhu WZ et al: Remote ischemic preconditioning protects neurocognitive function of rats following cerebral hypoperfusion. Med Sci Monit, 2011; 17(11): BR299-304
5. Ghosh S, Hayden MS: New regulators of NF-kappaB in inflammation. Nat Rev Immunol, 2008; 8: 837-48
6. Ghosh S, May MJ, Kopp EB: NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol, 1998; 16: 225-60
7. Karin M: The beginning of the end: IkappaB kinase (IKK) and NFkappaB activation. J Biol Chem, 1999; 274: 27339-42
8. Baldwin AS Jr: The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol, 1996; 14: 649-83
9. Wei-Kang G, Dong-Liang Z, Xin-Xin W et al: Actin cytoskeleton modulates ADMA-induced NF-kappaB nuclear translocation and ICAM-1 expression in endothelial cells. Med Sci Monit, 2011; 17(9): BR242-47
10. Nurmi A, Lindsberg PJ, Koistinaho M et al: Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. Stroke, 2004; 35: 987-91
11. Schneider A, Martin-Villalba A, Weih F et al: NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med, 1999; 5: 554-59
12. Li J, Lu Z, Li WL et al: Cell death and proliferation in NF-kappaB p50 knockout mouse after cerebral ischemia. Brain Res, 2008; 1230: 281-89
13. Mito T, Nemoto M, Kwansa H et al: Decreased damage from transient focal cerebral ischemia by transfusion of zero-link hemoglobin polymers in mouse. Stroke, 2009; 40: 278-84
14. Baeuerle PA: IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell, 1998; 95: 729-31
15. Traenckner EB, Pahl HL, Henkel T et al: Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. Embo J, 1995; 14: 2876-83
16. Brockman JA, Scherer DC, McKinsey TA et al: Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol Cell Biol, 1995; 15: 2809-18
17. Ferreira V, Tarantino N, Korner M: Discrimination between RelA and RelB transcriptional regulation by a dominant negative mutant of IkappaBalpha. J Biol Chem, 1998; 273: 592-99
18. Ferreira V, Sidenius N, Tarantino N et al: In vivo inhibition of NF-kappa B in T-lineage cells leads to a dramatic decrease in cell proliferation and cytokine production and to increased cell apoptosis in response to mitogenic stimuli, but not to abnormal thymopoiesis. J Immunol, 1999; 162: 6442-50
19. Liu ALHBR, Sen DM: Cloning and sequence analysis of Chinese IkBa gene. Mianyixue Zazhi, 2002; 18: 81-84
20. Longa EZ, Weinstein PR, Carlson S, Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 1989; 20: 84-91
21. Ata KA, Lennmyr F, Funa K et al: Expression of transforming growth factor-beta1, 2, 3 isoforms and type I and II receptors in acute focal cerebral ischemia: an immunohistochemical study in rat after transient and permanent occlusion of middle cerebral artery. Acta Neuropathol, 1999; 97: 447-55
22. Dixon EP, Stephenson DT, Clemens JA, Little SP: Bcl-Xshort is elevated following severe global ischemia in rat brains. Brain Res, 1997; 776: 222-29
23. Carroll JE, Hess DC, Howard EF, Hill WD: Is nuclear factor-kappaB a good treatment target in brain ischemia/reperfusion injury? Neuroreport, 2000; 11: R1-4
24. Blondeau N, Widmann C, Lazdunski M, Heurteaux C: Activation of the nuclear factor-kappaB is a key event in brain tolerance. J Neurosci, 2001; 21: 4668-77
25. Ravati A, Ahlemeyer B, Becker A et al: Preconditioning-induced neuroprotection is mediated by reactive oxygen species and activation of the transcription factor nuclear factor-kappaB. J Neurochem, 2001; 78: 909-19